CC
BSX icon

Cedar Capital’s Boston Scientific BSX Stock Holding History

Cedar Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,659
Closed -$904K – 72
2020
Q3 		$904K Buy
23,659
+7,173
+44% +$276K 0.3% 93
2020
Q2 		$579K Buy
16,486
+1,007
+7% +$36.3K 0.22% 101
2020
Q1 		$505K Sell
15,479
-218
-1% -$8.52K 0.24% 97
2019
Q4 		$710K Buy
15,697
+3,460
+28% +$145K 0.33% 103
2019
Q3 		$498K Buy
12,237
+2,837
+30% +$120K 0.23% 118
2019
Q2 		$404K Sell
9,400
-380
-4% -$14.6K 0.17% 123
2019
Q1 		$375K Sell
9,780
-637
-6% -$24.3K 0.17% 128
2018
Q4 		$368K Sell
10,417
-2,362
-18% -$85.7K 0.19% 119
2018
Q3 		$492K Buy
12,779
+3,939
+45% +$138K 0.19% 121
2018
Q2 		$289K Buy
+8,840
New +$267K 0.13% 131

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Cedar Capital's BSX Position: Q4 2020 in Review

Cedar Capital sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 23,659 shares — an estimated $904K sold.

Cedar Capital first reported a position in BSX in Q2 2018 and held it in 10 quarters. The position peaked at $904K in Q3 2020. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Cedar Capital reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 23,659 Boston Scientific shares in Q4 2020, an estimated $904K.
  • Cedar Capital first reported a position in Boston Scientific in Q2 2018 and held it in 10 quarters.
  • Cedar Capital's Boston Scientific position peaked at $904K in Q3 2020.
  • 863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.